초록 ▼

A process for the production of a aerated frozen products by preparing a mixture of ingredients suitable for a frozen aerated product, adding an emulsifier mixture, aerating the mix to obtain an aerated mix having an overrun of about 20% to about 250%, and about 5% to about 100% for the frozen aerat

A process for the production of a aerated frozen products by preparing a mixture of ingredients suitable for a frozen aerated product, adding an emulsifier mixture, aerating the mix to obtain an aerated mix having an overrun of about 20% to about 250%, and about 5% to about 100% for the frozen aerated ice cream and water ice, respectively, and freezing the aerated mix to produce the aerated ice cream or water ice.

대표청구항 ▼

A process for the production of a aerated frozen products by preparing a mixture of ingredients suitable for a frozen aerated product, adding an emulsifier mixture, aerating the mix to obtain an aerated mix having an overrun of about 20% to about 250%, and about 5% to about 100% for the frozen aerat

A process for the production of a aerated frozen products by preparing a mixture of ingredients suitable for a frozen aerated product, adding an emulsifier mixture, aerating the mix to obtain an aerated mix having an overrun of about 20% to about 250%, and about 5% to about 100% for the frozen aerated ice cream and water ice, respectively, and freezing the aerated mix to produce the aerated ice cream or water ice. s," Clin. Chim. Acta, vol. 34, pp. 425-429 (1971). Tamari, et al., "Etudes sur les Phosphonolipides de la Bile de Boeuf," Agr. Biol. Chem., vol. 40, No. 10, pp. 2057-2062 (1976). Thirlwell, et al., "Phase I-II Trial of an unconventional agent, virulizin, in patients with advanced cancer," J. Cancer Res. Clin. Oncol., A1.240.01, pp. 51 (1990). Warner, et al., "Phase II trial of Virulizin in patients with pancreatic cancer," Clin. Invest. Med., vol. 17, No. 1, pp. 37-41. Balch and Houghton, "Diagnosis of Metastic Melanoma at Distant Sites," in "Cutaneous Melanoma," 2d ed. (J.P. Lippincott Company, Philadelphia, PA, 1992). Smith, et al., Anal. Biochem . . . , 150: pp. 76-85 (1985). Warner, et al., "Phase II Study of virulizin in Patients With Pancreatic Cancer," Clinical and Investigative Medicine Supplement, vol. 15, No. 4, pp. A89, Abstract 546 (Aug. 1992). De La Garza, et al., "Phase II Trial of New Agent Virulizin (VZ) in Patients with Advanced Malignant Melanoma," Baylor College of Medicine Research Symposium, Houston, TX, Apr. 15, 1993. (See Footnote No. 1). De La Garza, et al., "Phase II Trials of a New Agent, Virulizin (VZ) in Patients with Metastatic Melanoma and GI-Cancer," 2ndInt'l Congress on Biological Response Modifiers, San Diego, CA, Jan. 29-31, 1993. (See Footnote No. 1). Kabuta, et al., "The Prevention and Therapy by Simian Liver Extract and Bovine Gallbladder Bile Against Herpes Simplex Virus Infected Mice," J. Kuruma Med. Assoc., 48(6), 443-448 (1985). (See Footnote No. 1). Munder, et al., "Alkyllylsophospholipids in Cancer Therapy," Augmenting Agents in Cancer Therapy, pp. 441-458, Hersh et al., eds. (Raven Press, NY, 1981). (See Footnote No. 1). Ren, et al., "The effects of swine acids-sodium salt on the inhibition of proliferation and induction of differentiation in human promyelocytic leukemia cell line HL-60," Chinese J. of Pharm. and Toxic., 3(3), 236-240 (1989). (See Footnote No. 1).